OSLER DIAGNOSTICS LIMITED (10001467) is a private limited company registered in OXFORD, incorporated in 2016. The company operates in the research and experimental development on biotechnology sector. Our database holds 29 signals from 12 official sources covering this company's filings, appointments, and regulatory records. The current risk score is 73/100, classified as "stable". Note: the company's accounts appear to be overdue.
OSLER DIAGNOSTICS LIMITED is an active private limited company incorporated in Oxford in 2016, operating within the research and experimental development of biotechnology. The company provides comprehensive diagnostic testing with high-performance capabilities that are quantitative, accurate, sensitive, and multiplexed. It consolidates multiple existing systems onto a single instrument to offer unconstrained and uncompromised diagnostic solutions for anyone, anywhere.
Standard data coverage across 12 sources. Risk score of 73 — no major risk signals detected.
OSLER DIAGNOSTICS LIMITED is 1 of 129 research and experimental development on biotechnology companies in OXFORD, out of 4,024 active companies in this sector nationally (4,909 including dissolved).
44 employees as of 31 Dec 2020.
| Year | Turnover | Profit | Net Assets |
|---|---|---|---|
| 31 Dec 2020 | — | -£17.3M | — |
OSLER DIAGNOSTICS LIMITED has received 5 Innovate UK grants. This demonstrates a strong commitment to research and innovation.
This company profile is built from 10 official data sources: Ch Officers, Companies House, GLEIF, Gateway to Research, HMRC Trade Info, ICO, Innovate UK, Modern Slavery Registry, Uk Trade Info, WHOIS.
OSLER DIAGNOSTICS LIMITED is an active private limited company incorporated in Oxford in 2016, operating within the research and experimental development of biotechnology.
Current directors include MR CONNOR CAMPBELL, MR ANDRE CRAWFORD-BRUNT, MR PAUL MICHAEL DIXON and 2 more.
OSLER DIAGNOSTICS LIMITED is registered in OXFORD, United Kingdom.
OSLER DIAGNOSTICS LIMITED operates under SIC code 72110 — Research and experimental development on biotechnology.
OSLER DIAGNOSTICS LIMITED has a risk score of 73 out of 100, classified as "Stable". This score is calculated from 29 data signals across 12 government sources.
The next accounts for OSLER DIAGNOSTICS LIMITED are due on 30 Sept 2026 — this filing is currently overdue.
Yes, OSLER DIAGNOSTICS LIMITED was previously known as OXFORD IMPEDANCE DIAGNOSTICS LIMITED.
OSLER DIAGNOSTICS LIMITED offers Osler Origin, Osler HemaTap.
According to the latest filed accounts (31 Dec 2020), OSLER DIAGNOSTICS LIMITED has 44 employees.
The dissolution rate for the research and experimental development on biotechnology sector in the UK is 12.2%. The average company age in this sector is 7.2 years.
OSLER DIAGNOSTICS LIMITED is currently listed as "Active" on Companies House, indicating it is still a registered company. An "Active" status means the company has not been dissolved, struck off, or entered into liquidation.
OSLER DIAGNOSTICS LIMITED is registered as a Private Limited Company, which is a company limited by shares whose shares are not offered to the general public. It is the most common type of UK company, offering limited liability to its shareholders.
OSLER DIAGNOSTICS LIMITED was incorporated on 11 Feb 2016, making it 10 years old. The company remains active and in good standing.
OSLER DIAGNOSTICS LIMITED is classified under SIC code 72110 (Research and experimental development on biotechnology). The Standard Industrial Classification system is used by the UK government to categorise businesses by their primary economic activity.
We track 29 data signals from 12 official government sources for OSLER DIAGNOSTICS LIMITED.